In streptozotocin- (STZ-) induced AD model rats, injection of geniposide at 50 μM to the lateral ventricle reduced STZ-induced spatial learning deficit, tau phosphorylation, and GSK-3β hyperactivity. Here, MAPT is linked to Alzheimer disease.